Answers are grounded in this paper and cite their sources.
In France, CRS/HIPEC is a safe procedure with an acceptable 90-day POM that could even be improved through centralization in high-volume centers.
No takes yet. Share an insight, caveat, or question.
Noiret et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: